Transdermal delivery of levonorgestrel. VII. In vivo studies

Contraception
D R FriendS Phillips

Abstract

This paper describes the results of transdermal experiments performed in vivo using devices designed for delivery of levonorgestrel. To help evaluate the performance of the transdermal devices on rabbits, a constant infusion experiment was performed using osmotic pumps. Reservoir-type transdermal devices were prepared and tested on rabbits for their ability to deliver 30 to 35 micrograms/d of levonorgestrel. Ethyl acetate and ethanol (0.7:0.3) or neat ethyl acetate were used as permeation enhancers. The results indicated that for rabbits, a rate-limiting membrane was required to control the delivery of enhancer(s) to the skin so that constant plasma levels could be maintained. The devices induced mild erythema and very mild edema over the 24-hour exposure period. The potential use of such a transdermal delivery system in humans is discussed.

References

Jun 1, 1989·Journal of Pharmaceutical Sciences·D R FriendM Okagaki
Mar 15, 1982·Toxicology and Applied Pharmacology·R L BronaughE R Congdon

❮ Previous
Next ❯

Citations

Jan 1, 1991·Medicinal Research Reviews·D R Friend
Sep 1, 1991·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·D R FriendJ R Hill

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.